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This thesis addresses corporate approaches to CSR stakeholder engagement in the 
pharmaceutical industry in the UK and Germany. Its objective is to undertake mainly 
exploratory qualitative research to investigate how the selected sample manages CSR. The 
data was primarily accessed and collected from senior executives within major 
pharmaceutical companies. Multiple research methods were employed to gather rich new 
empirical evidence which focuses on the CSR practices and perceptions of CSR managers in 
both countries. To examine how this ‘sensitive’ sector responds to what could be termed the 
‘CSR Challenge’, a critical realist perspective and six codes were chosen to map the practices 
and to compare similarities and differences between the two countries. This research 
contributes to the academic literature in this field by filling significant gaps in an area which 
was previously under-investigated. Ultimately, the findings are employed to examine a pre-
specified framework which was originally developed by the author based on secondary data in 
separate research. Overall, the results inform, re-examine, and improve this recently published 
framework. The updated explanatory framework which results from the research is the main 
conceptual contribution of the thesis. It serves as a management tool which includes the 
contextual factors which influence decision-makers’ practices and perceptions portrayed as a 
set of inter-related management steps. This new conceptualisation is designed to be of 
practical use for decision-makers when managing their stakeholder engagement activities. As 
a result, this research is essentially applied and normative in nature. In addition, this work 
presents an original contribution to the literature in its field which should be of interest to 
academics. 
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(i) 
                     
BACKGROUND 
This PhD thesis is submitted in December 2010 to fulfil the final requirement of part-time 
doctoral research at Bradford University School of Management in the UK under the 
supervision of Dr. Jenny Fairbrass and Professor Frank McDonald.  
 
The personal and academic motivation for the research arises out of a long-standing interest in 
the topic of business ethics which originated from time spent during childhood in West 
Africa. From the perspective of a person who originates from a western industrialised 
scientific culture, based on a Christian, Eurocentric world view, those experiences triggered 
significant questions, concerns, and challenges. My resulting personal interest in human rights 
and the appropriate role for business in the third world dilemma initially sparked my 
academic interest in this area. My first academic publication comprised a thesis for a business 
studies degree entitled “Trans-national Corporations and the Third World” (O’Riordan, 1990). 
That thesis examined the ethics, dilemmas, and implications for business of marketing 
products to the third world. It concluded that contrary to the prevailing belief at the time, 
trans-national companies were one of the major sources of ‘support’ in the developing world.  
 
In the meantime, many of the questions and challenges addressed in that thesis have resurged 
during my over twelve years of international business experience (mainly in the 
pharmaceutical industry in various general management functions in Europe and the US, but 
particularly in Germany, the UK, and Ireland). Working since 2004 as a lecturer at German 
Universities both facilitates and has re-kindled my interest in the academic study of CSR.  
 
While much has been written on this topic over the last fifteen to twenty years, the realisation 
that past scholarship in the field of CSR stakeholder management for the pharmaceutical 
industry in the UK and Germany requires improvement provides both the academic and social 
rationale for undertaking this research. 
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GLOSSARY OF KEY TERMS 
 
Pharmaceutical Industry is defined as the collection of those public and private 
organisations involved in the discovery, development, manufacture, and/or selling of 
pharmaceutical products or preparations.  Pharmaceutical products or preparations are defined 
to include drugs and medications, biotechnological products, medical diagnostics and devices, 
as well as medications to treat animals. 
 
Pharmaceutical Company in the UK and Germany is defined as a single subsidiary of a 
pharmaceutical TNC operating either in the UK or Germany. This definition focuses on 
country of operation and not the original country of origin of those companies operating in 
this chosen location. For clarification, this means that for example if the subsidiary of a 
Danish or Japanese company ranks (according to industry statistics) as a leading company in 
the UK or German pharmaceutical market (see below), it is included as a prospective 
candidate in the target sample. 
 
Leading Pharmaceutical Company in the UK or Germany is defined based on industry 
sales figures (IMS, 2006) and rankings of the leading pharmaceutical companies by sales 
turnover in both target country in the year 2006 (when the data collection was initiated). 
 
Society is defined as a nation or a broad grouping of people having common traditions, 
values, institutions, and collective activities and interests. Accordingly, business relationships 
exist with communities at all levels from global to national (e.g. countries), to local (e.g. 
cities) and business communities (e.g. consumers, investors, minorities etc.). For clarification, 
a society’s pluralistic nature (i.e. the diffusion or degree of decentralisation and diversity of 
power) determines the relationships between business and society relationships among 
society’s many groups and organisations (Buchholtz and Carroll, 2009:8). 
 
(vi) 
                     
Stakeholders are defined as those groups and individuals who can affect or are affected by 
the achievement of an organisation’s mission (Freeman (1984:52) or all those with a critical 
eye on corporate actors (Bowmann-Larsen and Wiggen 2004). 
Stakeholder Management constitutes a whole range of formal and informal business 
activities including production, marketing, accounting, human resources, and so on. It 
involves the decision-making processes of planning, leading, organising, implementing and 
controlling stakeholder engagement. This includes managing business relationships via 
policies, practices, and programmes such as stakeholder prioritisation and other choices about 
how to engage with stakeholders (adapted from Crane and Matten, 2004:144). 
Stakeholder Engagement is defined as practices to involve stakeholders in a positive manner 
in organisational activities (Greenwood, 2007:317). It comprises establishing, developing, and 
maintaining stakeholder relations. This includes stakeholder identification, consultation, 
communication, dialogue, and exchange (Burchell and Cook, 2006; Greenwood, 2007:322). 
CSR (Corporate Social Responsibility) CSR is defined as the integration of social and 
environmental values within a company’s core business operations and […] engagement with 
stakeholders to improve the well-being of society (World Business Council on Sustainable 
Development 2002:6).  
CSR Behaviour is defined as a combination of approach, management, and policy. Six codes 
are chosen to examine the relevant characteristics of responsible stakeholder management. 
They form the basis upon which the data is collected, analysed and presented. They include: 
• Terminology: This code is defined as the label(s) or term(s) chosen by the target 
companies to communicate their socially responsible activities.  
• Stakeholders: This code is defined to include: the presence of or reference to the 
word ‘stakeholder’ on the company website; evidence of its use and relevance to CSR; 
and how stakeholders are identified and prioritised.  
(vii) 
                     
• Communication/Dialogue: This code is defined (based on the definition of 
stakeholder dialogue) as a vehicle for the exchange of CSR offerings between the firm 
and its societal publics or stakeholders (Murray and Vogel 1997:142). This research 
specifically illuminates this ‘exchange’ on aspects including how companies engage in 
stakeholder dialogue with the target companies. Accordingly, this code includes the 
concept of stakeholder engagement which is examined based on five specific 
indicators. These include ease of contact partner identification, helpfulness, speed and 
intensity of response, CSR knowledge and professionalism, and interest in continuing 
the dialogue. Other engagement aspects are addressed in the subsequent three codes. 
• Organisation/Governance: This code is defined as the internal management aspect 
involving how the target companies organise and position specific groups or functions 
with responsibility for managing CSR. It includes whether CSR is managed in a 
centralised or decentralised way by the target companies. While the external 
governance system (including legal requirements, adopted by or imposed upon 
companies in their operating environment) may influence CSR practice, this variable 
focuses more on how CSR stakeholder engagement is actually conducted internally.  
• Projects: This code is defined as the activities or policies (e.g. codes of conduct/other 
guidelines) undertaken within the claimed scope of socially responsible activities. 
• Expectations: This code is defined as the likely benefits which are envisaged to be 
achieved by investing resources in socially responsible activities. 
For clarification, from amidst the range of terminology from which to label responsible 
business practices, the term ‘CSR’ (i.e. corporate social responsibility) has been chosen to 
signify the concept of CSR defined above (WBSCD, 2002:6). This choice is based on the 
rationale of this term’s frequent adoption in Europe (e.g. Fairbrass et al, 2005; Crane and 
Matten, 2007). 
(viii) 
